Provoking Our Inner Stem Cells

July 17, 2009 | Source: Technology Review

Fate Therapeutics aims to harness the body’s ability to heal itself by developing drugs that stimulate resident stem cells.

The company began its first clinical trial in May of a novel molecule that could make cord-blood transplants more effective by enhancing the activity of the stem cells that create the blood and the immune system.